Impact of High Cholesterol on Cardiovascular Disease Risk in Women
Study Findings on Lipoprotein Levels
A recent study indicates that elevated blood plasma lipoprotein levels are significantly linked to an increased risk of cardiovascular disease (CVD) in women. Certain types of plasma lipoprotein can be lowered through lifestyle changes such as diet and exercise. However, lipoprotein(a) levels are primarily influenced by genetics and cannot be easily modified through these means.
30-Year CVD Risk and Lipoprotein(a)
The research highlights that high levels of lipoprotein(a) are associated with a greater 30-year risk of developing CVD, even among women who are otherwise healthy. The study’s authors advocate for the implementation of routine screening to identify individuals with elevated lipoprotein(a) levels, which could lead to timely preventive measures.
Global CVD Statistics
According to the World Health Organization, in 2022, cardiovascular diseases, including strokes and heart attacks, accounted for 32% of all deaths and 38% of premature deaths worldwide. Elevated total blood plasma cholesterol, especially low-density lipoprotein (LDL-C), is a known risk factor for CVD. Conversely, high-density lipoprotein (HDL), often referred to as ‘good’ cholesterol, can help mitigate this risk.
Managing Cholesterol Levels
To manage cholesterol levels effectively, individuals are encouraged to adopt a healthy diet, engage in regular physical activity, refrain from smoking, and, if necessary, use medications such as statins. However, the unique nature of lipoprotein(a) means that its levels are largely dictated by genetics, limiting the impact of lifestyle changes.
Study Leadership and Recommendations
The study, conducted by researchers at Brigham and Women’s Hospital in Boston and published in JAMA Cardiology, recommends that healthcare professionals consider routine screening for lipoprotein(a). Lead author Dr. Ask T. Nordestgaard, a postdoctoral research fellow in the Division of Preventive Medicine at Brigham and Women’s Hospital, emphasized the significance of their findings, stating, “I believe our findings are very important, since they really show how strong a predictor of long-term CVD risk elevated Lp(a) levels are even among healthy women.”
Dr. Nordestgaard further noted, “Our findings highlight the importance of screening for elevated Lp(a) levels among healthy individuals, primarily to initiate primary preventive measures for those with extreme elevations.”